BioSpace News Archive

AnPac Bio-Medical Science Co., Ltd. announced today that on December 30, 2021, the Company’s Class III medical device for lung cancer auxiliary diagnosis has completed and passed stringent and rigorous registration tests at the testing laboratory.

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the “Company”), today announced the completion of its Phase 1 clinical trial of 18-MC, the Company’s non-hallucinogenic proprietary derivative of ibogaine, being developed for the treatment of indications linked to opioid use disorder.

Titan Medical Inc. announced today that it completed, on schedule, the final milestone under the development and license agreement with Medtronic plc (NYSE: MDT), the world’s leading medical technology company.

Protara Therapeutics, Inc., a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, announced that management will present at the H.C. Wainwright BioConnect Virtual Conference being held from January 10-13, 2022.

iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, reported select preliminary, unaudited financial results for the fourth quarter and full year of 2021.

Erasca, Inc. today announced its participation in the 40th annual J.P. Morgan Healthcare Conference. of the company and pipeline at 3:45 pm Eastern Time on Monday, January 10, 2022.

Cocrystal Pharma, Inc. announces that management will present a company overview at the H.C. Wainwright BioConnect Virtual Conference being held January 10-13, 2022.

Vaccinex, Inc. (Nasdaq: VCNX, Vaccinex, the Company), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease through the inhibition of SEMA4D, today reported positive interim safety data in the Phase Ib “safety run-in” segment of the KEYNOTE B84 combination study of Keytruda®.

AbbVie (NYSE: ABBV) will participate in the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022.

Convey Health Solutions Holdings, Inc. announced today that Stephen Farrell , Chief Executive Officer, Tim Fairbanks , Chief Financial Officer, and John Steele Executive Vice President, Technology, will participate in the 40th Annual J.P. Morgan Healthcare Conference including a virtual fireside chat presentation at 9:45 a.m. (ET) on Tuesday, January 11, 2022.